The Global Proteinase K Industry is on track for stable expansion, with a projected valuation of US$43.9 million by 2033. This translates to a consistent Compound Annual Growth Rate (CAGR) of 4.8% anticipated from 2023 to 2033. The market is estimated to be valued at US$27.5 million in 2023, highlighting its growing importance in various scientific applications.
A plethora of factors are expected to impact the growth of the Global Proteinase K Industry. A significant rise in research and development activities, lesser production costs, broader application of Proteinase K, and good product stability and specificity of Proteinase K will give a massive push to the revenue growth of the Global Proteinase K Industry by the end of the forecast period. A steady rise of chronic diseases and better government-backed investment channels to fund advanced research and development are expected to boost the expansion of the Global Proteinase K Industry throughout the assessment. An increasing number of research activities, soaring expenditure on personal healthcare, and increasing adoption of gene therapy have been significantly high in the U.S. market in recent years, making North America the most lucrative regional market for Proteinase K.
Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-2399
Global Proteinase K Industry: Segmental Forecast
- By form, the lyophilized powder form segment is anticipated to account for a higher revenue share in the global Proteinase K as compared to the liquid form segment. Lyophilized powder from the segment is expected to reach a market value of US$ 19.2 Mn by 2026, reflecting a CAGR of 6.3% over the forecast period. The growth in lyophilized powder form can be attributed to the increasing advantages of powder form over liquid form in the case of storage and preservation of samples.
- By application, purification of DNA & RNA segment will account for the highest revenue share in the Global Proteinase K Industry as compared to other applications of Proteinase K. Purification of DNA & RNA segment is expected to reach a value of US$ 19.2 Mn by 2026, reflecting a CAGR of 6.5% over the forecast period.
- By end user, the biotechnology companies segment is expected to project higher demand for Proteinase K as compared to other end-user segments such as academic institutes and diagnostics laboratories. The strong growth in biotechnology companies can be attributed to an increasing use of Proteinase K in research and development and new drug discovery. The cost-effectiveness of Proteinase K over other reagents is the key factor responsible for its increasing use in biotechnology companies. The biotechnology companies segment is expected to register the highest CAGR of 6.7% over the forecast period.
Global Proteinase K Industry Regional Market Projections
Demand for research in academics and funding facilities provided by the U.S. government to support gene therapy and other activities for drug development is anticipated to boost the North American Proteinase K market. Followed by North America, Western Europe, and APEJ are the most lucrative regions in the global Proteinase K market and are anticipated to grow by 5.7% and 6.1% respectively over the forecast period. Increasing demand for drug development, rising hereditary diseases due to changing lifestyles, and growing disposable income are some of the factors expected to contribute to the growth of the Global Proteinase K Industry.
Global Proteinase K Industry: Vendor Insights
Top companies profiled in the Global Proteinase K Industry report include Thermo Fisher Scientific Inc., Merck KGaA, Qiagen N.V., Worthington Biochemical Corporation, Sisco Research Laboratories Pvt. Ltd, Promega Corporation, Bioline and F. Hoffmann-La Roche AG among others. Leading market players are adopting different strategies such as product launches and acquisitions to maintain their market share. For instance, in November 2015, Merck KGaA acquired Sigma-Aldrich to strengthen and expand its consumable and reagent portfolio.
Click Here To Buy Your Detailed Report
https://www.futuremarketinsights.com/checkout/2399
Global Proteinase K Industry Segmentation Form
- Lyophilized Powder Form
- Liquid Form
Application
- Isolation and purification of genomic DNA & RNA
- In Situ Hybridization
- Mitochondria isolation
- Enzyme Removal
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube